The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
about
The SNX-PX-BAR family in macropinocytosis: the regulation of macropinosome formation by SNX-PX-BAR proteinsVoltage-Controlled Enzymes: The New JanusBifronsMain roads to melanomaThe lipid phosphatase activity of PTEN is critical for its tumor supressor functionHuman PIR1 of the protein-tyrosine phosphatase superfamily has RNA 5'-triphosphatase and diphosphatase activitiesThe tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal regionInteraction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinaseEvidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulationMyotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphatePTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1Ubiquitination regulates PTEN nuclear import and tumor suppressionPhosphatase of regenerating liver 2 (PRL2) is essential for placental development by down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and activating Akt proteinSKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation.Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein functionLoss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivationNHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membraneThe forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanismPTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.Should individual PI3 kinase isoforms be targeted in cancer?Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chipsNuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent mannerPurinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatasesPTEN represses RNA Polymerase I transcription by disrupting the SL1 complexRole of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesisThe Phox homology (PX) domain, a new player in phosphoinositide signallingPlatelet-derived growth factor-BB-mediated glycosaminoglycan synthesis is transduced through AktSEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactionsOverexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activityPTEN as an effector in the signaling of antimigratory G protein-coupled receptorAnalysis of the genome to personalize therapy for melanomaLong-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in miceProtein kinases and phosphatases in the control of cell fateMolecular biology of lung cancer: clinical implicationsRetroviral oncogenes: a historical primerActivation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2aProtean PTEN: form and functionProtein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction
P2860
Q21091096-12334CB8-4884-49DE-891B-AB36C64ADBCFQ21129281-924A075B-CA0F-4665-8D52-C3982E7E113DQ21245465-617B5DC2-D0E3-4BA1-8596-64D9E3DAFD1CQ22007981-01F46ADC-7CF3-4C5A-9C56-F97F450144CBQ22009915-14E44E44-F471-47A1-A7AB-29C39659A13BQ22010498-D4313CA7-A492-47CB-8A84-18512C3F64CEQ22253438-5F23A1AC-FCEC-4BB9-AED4-C72519A7279BQ22253866-256520FE-D74B-4C98-9CF3-E6714CC9400BQ22254461-644B6F5D-6E34-46F0-BBD4-BA416CD2A644Q22254632-2C2373C8-4F5A-4AC7-B4F8-2F421F5B05DEQ22254699-E466F8BD-A3BC-4813-9077-78C8D966C4FBQ24292946-88488214-DC5D-49EC-8B61-DEFE4B8632EBQ24293081-FCEA7185-3122-4BD6-A82D-09F8307E9D1BQ24293490-0F50BC6A-84B1-4E6B-BE78-36A2C6D8CBD0Q24295164-797758E2-C823-423D-8C44-AB4E5F9699C2Q24297357-71F291B0-9537-4921-950C-E2E7A5D7DBECQ24298305-B5DD4C05-E671-4125-B5FD-80E1E38BE5B0Q24302271-4E92EA5D-AB27-4F67-9782-3A507024A72EQ24303571-0B162F30-73C0-4867-BE49-43EBB455E50DQ24304324-EFBE0378-96DB-43E7-B943-9170CE5E04B2Q24309044-07A5F578-C3F4-44EE-B6CA-334CE3527192Q24314346-7A0AA2CB-37FA-4072-933A-48E84D6FA18CQ24337323-3C3EB54E-AC86-4EB1-B38C-B0649285C626Q24337816-1D756872-501E-4638-8B74-72E004E3867FQ24529900-4D804037-1F62-40B8-B1F5-C83282174CB9Q24531380-2F0324BA-B1E5-4C22-B50B-3A96322A66A1Q24531835-694E91B6-73F2-46B7-A1D1-D44666EF5EB9Q24533547-A1D73103-2148-4FFC-BB47-B2E0556D1B8EQ24533977-6166E57F-AD85-4EE5-950E-D82B3FA520BDQ24550889-21935E4A-787A-455A-AB31-9146BE57ED5EQ24551012-4E002DFF-5051-4E0B-87E2-B31ACBB192C8Q24555751-8D6A84C7-0541-4592-9B2F-090418D5F95DQ24601008-7C0F0134-5583-44ED-A241-40D0676E6DE0Q24603933-130AECB7-108D-4764-B4C8-3D06430EA2DFQ24604987-C3AFDB01-E083-47D1-A4E5-2B868C07FBBDQ24610335-A9EE173B-2A4A-4D34-9F1E-6C3EC333D1EEQ24611142-26A15884-4252-4176-81FD-C583749C2C47Q24613036-D54DF81B-9E39-4CE7-B573-E32D66F2D096Q24613810-3C341ED1-4D3F-486F-B10B-3A8431B7163AQ24622527-E329DF5A-DC7A-4102-BF34-EE7253D9F23B
P2860
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@ast
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@en
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@en-gb
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@nl
type
label
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@ast
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@en
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@en-gb
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@nl
prefLabel
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@ast
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@en
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@en-gb
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@nl
P3181
P356
P1476
The tumor suppressor, PTEN/MMA ...... ylinositol 3,4,5-trisphosphate
@en
P2093
P304
13375-13378
P3181
P356
10.1074/JBC.273.22.13375
P407
P577
1998-05-01T00:00:00Z